C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
167/215, 167/237
C07D 403/06 (2006.01) A61K 31/415 (2006.01) A61K 31/535 (2006.01) C07D 417/14 (2006.01)
Patent
CA 2027602
ALLGN.01A PATENT ABSTRACT OF DISCLOSURE The present invention relates to new racemic and optically active compounds containing a first moiety derived from a pilocarpine compound in which the furanone ring of pilocarpine is replaced by a hetero-ring containing a secondary nitrogen hetero- atom, and a second moiety derived from an epinephrine compound or a .beta.-adrenergic blocking compound, linked at the secondary nitrogen atom of the furanone-replacing hetero-ring of the pilocarpine compound and at the hydroxyl group of the epinephrine compound or of the .beta.-adrenergic blocking compound, via a carbonyl linker, and pharmaceutically acceptable acid addition salts thereof. The new compounds of the present invention are potent ocular hypotensives exhibiting minimal deleterious pupillary effects. GRD-5116
Allergan Inc.
Gowling Lafleur Henderson Llp
LandOfFree
Pharmaceutical epinephrine-pilocarpine derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical epinephrine-pilocarpine derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical epinephrine-pilocarpine derivatives will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1779790